BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen JS, Alfajaro MM, Wei J, Chow RD, Filler RB, Eisenbarth SC, Wilen CB. Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication. bioRxiv 2020:2020. [PMID: 32995789 DOI: 10.1101/2020.09.24.312769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou B, Li S, Ye J, Liu Y, Hu L, Tang Y, Wu Z, Zhang P. Immunopathological events surrounding IL-6 and IFN-α: A bridge for anti-lupus erythematosus drugs used to treat COVID-19. Int Immunopharmacol 2021;101:108254. [PMID: 34710657 DOI: 10.1016/j.intimp.2021.108254] [Reference Citation Analysis]
2 Chiang KC, Rizk JG, Nelson DJ, Krishnamurti L, Subbian S, Imig JD, Khan I, Reddy ST, Gupta A. Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath. Expert Opinion on Therapeutic Targets. [DOI: 10.1080/14728222.2022.2031975] [Reference Citation Analysis]
3 Pandolfi S, Chirumbolo S, Ricevuti G, Valdenassi L, Bjørklund G, Lysiuk R, Doşa MD, Lenchyk L, Fazio S. Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal. Basic Clin Pharmacol Toxicol 2021. [PMID: 34811895 DOI: 10.1111/bcpt.13690] [Reference Citation Analysis]
4 Kling J. Following the fate of cells in vivo. Lab Anim (NY) 2020;49:214-7. [PMID: 32704120 DOI: 10.1038/s41684-020-0602-5] [Reference Citation Analysis]
5 Abdel Shaheed C, Beardsley J, Day RO, McLachlan AJ. Immunomodulatory effects of pharmaceutical opioids and antipyretic analgesics: Mechanisms and relevance to infection. Br J Clin Pharmacol 2022. [PMID: 35229890 DOI: 10.1111/bcp.15281] [Reference Citation Analysis]
6 de Bruin N, Schneider A, Reus P, Talmon S, Ciesek S, Bojkova D, Cinatl J, Lodhi I, Charlesworth B, Sinclair S, Pennick G, Laughey WF, Gribbon P, Kannt A, Schiffmann S. Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection. IJMS 2022;23:1049. [DOI: 10.3390/ijms23031049] [Reference Citation Analysis]